Schmiegelow, K <br/><br/>
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.  [electronic resource] 

 -  Leukemia  Mar 2009 
 - 557-64 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2008.316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biotransformation--drug effects<br/>Child<br/>Child, Preschool<br/>DNA Damage<br/>Female<br/>Genotype<br/>Humans<br/>Inactivation, Metabolic--genetics<br/>Infant<br/>Male<br/>Mercaptopurine--administration & dosage<br/>Methylation<br/>Methyltransferases--analysis<br/>Neoplasm Proteins--analysis<br/>Neoplasms, Second Primary--enzymology<br/>Polymorphism, Genetic<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Recurrence<br/>Risk<br/>Scandinavian and Nordic Countries--epidemiology<br/>Thioguanine--administration & dosage